SCS Capital Management »

Dianthus Therapeutics shares owned by SCS Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by SCS Capital Management from 13F filings

Historical chart of SCS Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by SCS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by SCS Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $787k 9.4k 83.92
2025-12-31 $386k 9.4k 41.21
2025-09-30 $369k 9.4k 39.35

More positions owned by SCS Capital Management

Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Russell 3000 Etf (IWV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYM)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Series Trust State Street Spd (SPYG)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for SCS Capital Management

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Fairmount Funds Management
Wellington Management Company
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics